Investment analysts at TD Cowen began coverage on shares of CG Oncology (NASDAQ:CGON – Get Free Report) in a research report issued to clients and investors on Tuesday, MarketBeat.com reports. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback